Gene expression profiling in a mouse model of infantile neuronal ceroid lipofuscinosis reveals upregulation of immediate early genes and mediators of the inflammatory response

详细信息    查看全文

• 作者：Xingwen Qiao (1)
  Jui-Yun Lu (1)
  Sandra L Hofmann (1)
  
• 刊名：BMC Neuroscience
• 出版年：2007
• 出版时间：December 2007
• 年：2007
• 卷：8
• 期：1
• 全文大小：1369KB
• 参考文献：1. Haltia M: The neuronal ceroid-lipofuscinoses: from past to present. / Biochim Biophys Acta 2006,1762(10):850-56.
  2. Mole SE, Williams RE, Goebel HH: Correlations between genotype, ultrastructural morphology and clinical phenotype in the neuronal ceroid lipofuscinoses. / Neurogenetics 2005,6(3):107-26. 10.1007/s10048-005-0218-3">CrossRef
  3. Siintola E, Lehesjoki AE, Mole SE: Molecular genetics of the NCLs -- status and perspectives. / Biochim Biophys Acta 2006,1762(10):857-64.
  4. Kyttala A, Lahtinen U, Braulke T, Hofmann SL: Functional biology of the neuronal ceroid lipofuscinoses (NCL) proteins. / Biochim Biophys Acta 2006,1762(10):920-33.
  5. Vesa J, Hellsten E, Verkruyse LA, Camp LA, Rapola J, Santavuori P, Hofmann SL, Peltonen L: Mutations in the palmitoyl protein thioesterase gene causing infantile neuronal ceroid lipofuscinosis. / Nature 1995,376(6541):584-87. 10.1038/376584a0">CrossRef
  6. Lu JY, Verkruyse LA, Hofmann SL: Lipid thioesters derived from acylated proteins accumulate in infantile neuronal ceroid lipofuscinosis: correction of the defect in lymphoblasts by recombinant palmitoyl-protein thioesterase. / Proc Natl Acad Sci U S A 1996,93(19):10046-0050. 10.1073/pnas.93.19.10046">CrossRef
  7. Virmani T, Gupta P, Liu X, Kavalali ET, Hofmann SL: Progressively reduced synaptic vesicle pool size in cultured neurons derived from neuronal ceroid lipofuscinosis-1 knockout mice. / Neurobiol Dis 2005,20(2):314-23. 10.1016/j.nbd.2005.03.012">CrossRef
  8. Lehtovirta M, Kyttala A, Eskelinen EL, Hess M, Heinonen O, Jalanko A: Palmitoyl protein thioesterase (PPT) localizes into synaptosomes and synaptic vesicles in neurons: implications for infantile neuronal ceroid lipofuscinosis (INCL). / Hum Mol Genet 2001,10(1):69-5. 10.1093/hmg/10.1.69">CrossRef
  9. Ahtiainen L, Van Diggelen OP, Jalanko A, Kopra O: Palmitoyl protein thioesterase 1 is targeted to the axons in neurons. / J Comp Neurol 2003, 455:368-77. 10.1002/cne.10492">CrossRef
  10. Buff H, Smith AC, Korey CA: Genetic modifiers of Drosophila palmitoyl-protein thioesterase 1 induced degeneration. / Genetics 2007.
  11. Gupta P, Soyombo AA, Atashband A, Wisniewski KE, Shelton JM, Richardson JA, Hammer RE, Hofmann SL: Disruption of PPT1 or PPT2 causes neuronal ceroid lipofuscinosis in knockout mice. / Proc Natl Acad Sci U S A 2001,98(24):13566-3571. 10.1073/pnas.251485198">CrossRef
  12. Gupta P, Soyombo AA, Shelton JM, Wilkofsky IG, Wisniewski KE, Richardson JA, Hofmann SL: Disruption of PPT2 in mice causes an unusual lysosomal storage disorder with neurovisceral features. / Proc Natl Acad Sci U S A 2003,100(21):12325-2330. 10.1073/pnas.2033229100">CrossRef
  13. Wendt KD, Lei B, Schachtman TR, Tullis GE, Ibe ME, Katz ML: Behavioral assessment in mouse models of neuronal ceroid lipofuscinosis using a light-cued T-maze. / Behav Brain Res 2005,161(2):175-82. 10.1016/j.bbr.2005.02.024">CrossRef
  14. Jalanko A, Vesa J, Manninen T, von Schantz C, Minye H, Fabritius AL, Salonen T, Rapola J, Gentile M, Kopra O, Peltonen L: Mice with Ppt1(Deltaex4) mutation replicate the INCL phenotype and show an inflammation-associated loss of interneurons. / Neurobiol Dis 2005,18(1):226-41. 10.1016/j.nbd.2004.08.013">CrossRef
  15. Griffey MA, Wozniak D, Wong M, Bible E, Johnson K, Rothman SM, Wentz AE, Cooper JD, Sands MS: CNS-directed AAV2-mediated gene therapy ameliorates functional deficits in a murine model of infantile neuronal ceroid lipofuscinosis. / Mol Ther 2006,13(3):538-47. 10.1016/j.ymthe.2005.11.008">CrossRef
  16. Kielar C, Maddox L, Bible E, Pontikis CC, Macauley SL, Griffey MA, Wong M, Sands MS, Cooper JD: Successive neuron loss in the thalamus and cortex in a mouse model of infantile neuronal ceroid lipofuscinosis. / Neurobiol Dis 2007,25(1):150-62. 10.1016/j.nbd.2006.09.001">CrossRef
  17. Autti T, Raininko R, Santavuori P, Vanhanen SL, Poutanen VP, Haltia M: MRI of neuronal ceroid lipofuscinosis. II. Postmortem MRI and histopathological study of the brain in 16 cases of neuronal ceroid lipofuscinosis of juvenile or late infantile type. / Neuroradiology 1997,39(5):371-77. 10.1007/s002340050427">CrossRef
  18. Tusher VG, Tibshirani R, Chu G: Significance analysis of microarrays applied to the ionizing radiation response. / Proc Natl Acad Sci U S A 2001,98(9):5116-121. 10.1073/pnas.091062498">CrossRef
  19. Wang Y, Barbacioru C, Hyland F, Xiao W, Hunkapiller KL, Blake J, Chan F, Gonzalez C, Zhang L, Samaha RR: Large scale real-time PCR validation on gene expression measurements from two commercial long-oligonucleotide microarrays. / BMC Genomics 2006, 7:59. 10.1186/1471-2164-7-59">CrossRef
  20. Dal Zotto L, Quaderi NA, Elliott R, Lingerfelter PA, Carrel L, Valsecchi V, Montini E, Yen CH, Chapman V, Kalcheva I, Arrigo G, Zuffardi O, Thomas S, Willard HF, Ballabio A, Disteche CM, Rugarli EI: The mouse Mid1 gene: implications for the pathogenesis of Opitz syndrome and the evolution of the mammalian pseudoautosomal region. / Hum Mol Genet 1998,7(3):489-99. 10.1093/hmg/7.3.489">CrossRef
  21. National Institute of Allergy and Infectious Diseases NIH: The Database for Annotation, Visualization and Integrated Discovery 2006. [http://niaid.abcc.ncifcrf.gov/home.jsp]
  22. Papadopoulos MC, Manley GT, Krishna S, Verkman AS: Aquaporin-4 facilitates reabsorption of excess fluid in vasogenic brain edema. / FASEB J 2004,18(11):1291-293.
  23. Shibahara J, Kashima T, Kikuchi Y, Kunita A, Fukayama M: Podoplanin is expressed in subsets of tumors of the central nervous system. / Virchows Arch 2006,448(4):493-99. 10.1007/s00428-005-0133-x">CrossRef
  24. Riikonen R, Vanhanen S, Tyynela J, Santavuori P, Turpeinen U: CSF insulin-like growth factor-1 in infantile neuronal ceroid lipofuscinosis. / Neurology 2000,54(9):1828-832.
  25. Cooper JD, Messer A, Feng AK, Chua-Couzens J, Mobley WC: Apparent loss and hypertrophy of interneurons in a mouse model of neuronal ceroid lipofuscinosis: evidence for partial response to insulin-like growth factor-1 treatment. / J Neurosci 1999,19(7):2556-567.
  26. Dallner C, Woods AG, Deller T, Kirsch M, Hofmann HD: CNTF and CNTF receptor alpha are constitutively expressed by astrocytes in the mouse brain. / Glia 2002,37(4):374-78. 10.1002/glia.10048">CrossRef
  27. Henshall DC, Schindler CK, So NK, Lan JQ, Meller R, Simon RP: Death-associated protein kinase expression in human temporal lobe epilepsy. / Ann Neurol 2004,55(4):485-94. 10.1002/ana.20001">CrossRef
  28. Bialik S, Kimchi A: The death-associated protein kinases: structure, function, and beyond. / Annu Rev Biochem 2006, 75:189-10. 10.1146/annurev.biochem.75.103004.142615">CrossRef
  29. Cortes-Canteli M, Wagner M, Ansorge W, Perez-Castillo A: Microarray analysis supports a role for ccaat/enhancer-binding protein-beta in brain injury. / J Biol Chem 2004,279(14):14409-4417. 10.1074/jbc.M313253200">CrossRef
  30. Nadeau S, Hein P, Fernandes KJ, Peterson AC, Miller FD: A transcriptional role for C/EBP beta in the neuronal response to axonal injury. / Mol Cell Neurosci 2005,29(4):525-35. 10.1016/j.mcn.2005.04.004">CrossRef
  31. Wessells J, Yakar S, Johnson PF: Critical prosurvival roles for C/EBP beta and insulin-like growth factor I in macrophage tumor cells. / Mol Cell Biol 2004,24(8):3238-250. 10.1128/MCB.24.8.3238-3250.2004">CrossRef
  32. O'Donnell SL, Frederick TJ, Krady JK, Vannucci SJ, Wood TL: IGF-I and microglia/macrophage proliferation in the ischemic mouse brain. / Glia 2002,39(1):85-7. 10.1002/glia.10081">CrossRef
  33. Feinberg MW, Cao Z, Wara AK, Lebedeva MA, Senbanerjee S, Jain MK: Kruppel-like factor 4 is a mediator of proinflammatory signaling in macrophages. / J Biol Chem 2005,280(46):38247-8258. 10.1074/jbc.M509378200">CrossRef
  34. Zhang B, Kirov S, Snoddy J: WebGestalt: an integrated system for exploring gene sets in various biological contexts. / Nucleic Acids Res 2005,33(Web Server issue):W741-. 10.1093/nar/gki475">CrossRef
  35. Gerke V, Creutz CE, Moss SE: Annexins: linking Ca2+ signalling to membrane dynamics. / Nature reviews 2005,6(6):449-61.
  36. Munoz LE, Frey B, Pausch F, Baum W, Mueller RB, Brachvogel B, Poschl E, Rodel F, von der Mark K, Herrmann M, Gaipl US: The role of annexin A5 in the modulation of the immune response against dying and dead cells. / Current medicinal chemistry 2007,14(3):271-77. 10.2174/092986707779941131">CrossRef
  37. Tyynela J, Sohar I, Sleat DE, Gin RM, Donnelly RJ, Baumann M, Haltia M, Lobel P: A mutation in the ovine cathepsin D gene causes a congenital lysosomal storage disease with profound neurodegeneration. / Embo J 2000,19(12):2786-792. 10.1093/emboj/19.12.2786">CrossRef
  38. Lanahan A, Worley P: Immediate-early genes and synaptic function. / Neurobiol Learn Mem 1998,70(1-):37-3. 10.1006/nlme.1998.3836">CrossRef
  39. Clayton DF: The genomic action potential. / Neurobiol Learn Mem 2000,74(3):185-16. 10.1006/nlme.2000.3967">CrossRef
  40. Guzowski JF, Miyashita T, Chawla MK, Sanderson J, Maes LI, Houston FP, Lipa P, McNaughton BL, Worley PF, Barnes CA: Recent behavioral history modifies coupling between cell activity and Arc gene transcription in hippocampal CA1 neurons. / Proc Natl Acad Sci U S A 2006,103(4):1077-082. 10.1073/pnas.0505519103">CrossRef
  41. Mohler H: GABA(A) receptor diversity and pharmacology. / Cell and tissue research 2006,326(2):505-16. 10.1007/s00441-006-0284-3">CrossRef
  42. Bible E, Gupta P, Hofmann SL, Cooper JD: Regional and cellular neuropathology in the palmitoyl protein thioesterase-1 null mutant mouse model of infantile neuronal ceroid lipofuscinosis. / Neurobiol Dis 2004,16(2):346-59. 10.1016/j.nbd.2004.02.010">CrossRef
  43. Kageyama R, Ohtsuka T, Hatakeyama J, Ohsawa R: Roles of bHLH genes in neural stem cell differentiation. / Exp Cell Res 2005,306(2):343-48. 10.1016/j.yexcr.2005.03.015">CrossRef
  44. Elshatory Y, Brooks AI, Chattopadhyay S, Curran TM, Gupta P, Ramalingam V, Hofmann SL, Pearce DA: Early changes in gene expression in two models of Batten disease. / FEBS Lett 2003,538(1-):207-12. 10.1016/S0014-5793(03)00162-5">CrossRef
  45. Ohmi K, Greenberg DS, Rajavel KS, Ryazantsev S, Li HH, Neufeld EF: Activated microglia in cortex of mouse models of mucopolysaccharidoses I and IIIB. / Proc Natl Acad Sci U S A 2003,100(4):1902-907. 10.1073/pnas.252784899">CrossRef
  46. Wada R, Tifft CJ, Proia RL: Microglial activation precedes acute neurodegeneration in Sandhoff disease and is suppressed by bone marrow transplantation. / Proc Natl Acad Sci U S A 2000,97(20):10954-0959. 10.1073/pnas.97.20.10954">CrossRef
  47. Dhami R, Passini MA, Schuchman EH: Identification of novel biomarkers for Niemann-Pick disease using gene expression analysis of acid sphingomyelinase knockout mice. / Mol Ther 2006,13(3):556-64. 10.1016/j.ymthe.2005.08.020">CrossRef
  48. Kikuchi K, Yanagawa Y, Onoe K: CCR7 ligand-enhanced phagocytosis of various antigens in mature dendritic cells-time course and antigen distribution different from phagocytosis in immature dendritic cells. / Microbiol Immunol 2005,49(6):535-44.
  49. Zhang Z, Lee YC, Kim SJ, Choi MS, Tsai PC, Saha A, Wei H, Xu Y, Xiao YJ, Zhang P, Heffer A, Mukherjee AB: Production of lysophosphatidylcholine by cPLA2 in the brain of mice lacking PPT1 is a signal for phagocyte infiltration. / Hum Mol Genet 2007.
  50. Ahtiainen L, Kolikova J, Mutka AL, Luiro K, Gentile M, Ikonen E, Khiroug L, Jalanko A, Kopra O: Palmitoyl protein thioesterase 1 (Ppt1)-deficient mouse neurons show alterations in cholesterol metabolism and calcium homeostasis prior to synaptic dysfunction. / Neurobiol Dis 2007.
  51. Gene Expression Omnibus[http://www.ncbi.nlm.nih.gov/geo]
  52. NIH Neuroscience Microarray Consortium [http://arrayconsortium.tgen.org/np2/viewProject.do?action=viewProject&projectId=89]
  53. NIH Neuroscience Microarray Consortium[http://arrayconsortium.tgen.org/np2/viewProject.do?action=viewProject&projectId=264940]
  54. NIH Neuroscience Microarray Consortium [http://arrayconsortium.tgen.org/np2/home.do][http://arrayconsortium.tgen.org/np2/home.do]
  55. Affymetrix I: Statistical Algorithms Reference Guide. [http://www.affymetrix.com/support/technical/technotes/statistical_reference_guide.pdf]
  56. Biometric Research Branch (U.S. National Cancer Institute): BRB Array Tools . [http://linus.nci.nih.gov/BRB-ArrayTools.html]
  57. Technologies A: Genespring Technology Platform. [http://www.chem.agilent.com/Scripts/Generic.ASP?lPage=35082&indcol=Y&prodcol=Y]
  58. GeneGo I: Metacore Software. [http://www.genego.com/metacore.php]
  59. Massachusetts General Hospital CCIB Harvard Medical School: Primer Bank. [http://pga.mgh.harvard.edu/primerbank/]
  60. Java TreeView[http://jtreeview.sourceforge.net/]
  
• 作者单位：Xingwen Qiao (1)
  Jui-Yun Lu (1)
  Sandra L Hofmann (1)
  
  1. Hamon Center for Therapeutic Oncology Research and the Department of Internal Medicine, University of Texas Southwestern Medical Center, 75390, Dallas, TX, USA
  

文摘

Background The infantile form of neuronal ceroid lipofuscinosis (also known as infantile Batten disease) is caused by hereditary deficiency of a lysosomal enzyme, palmitoyl-protein thioesterase-1 (PPT1), and is characterized by severe cortical degeneration with blindness and cognitive and motor dysfunction. The PPT1-deficient knockout mouse recapitulates the key features of the disorder, including seizures and death by 7- months of age. In the current study, we compared gene expression profiles of whole brain from PPT1 knockout and normal mice at 3, 5 and 8 months of age to identify temporal changes in molecular pathways implicated in disease pathogenesis. Results A total of 267 genes were significantly (approximately 2-fold) up- or downregulated over the course of the disease. Immediate early genes (Arc, Cyr61, c-fos, jun-b, btg2, NR4A1) were among the first genes upregulated during the presymptomatic period whereas immune response genes dominated at later time points. Chemokine ligands and protease inhibitors were among the most transcriptionally responsive genes. Neuronal survival factors (IGF-1 and CNTF) and a negative regulator of neuronal apoptosis (DAP kinase-1) were upregulated late in the course of the disease. Few genes were downregulated; these included the α2 subunit of the GABA-A receptor, a component of cortical and hippocampal neurons, and Hes5, a transcription factor important in neuronal differentiation. Conclusion A molecular description of gene expression changes occurring in the brain throughout the course of neuronal ceroid lipofuscinosis suggests distinct phases of disease progression, provides clues to potential markers of disease activity, and points to new targets for therapy.